InnoPharmax Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 21.863 million compared to TWD 31.878 million a year ago. Operating loss was TWD 47.333 million compared to TWD 42.353 million a year ago. Net loss was TWD 47.814 million compared to TWD 46.573 million a year ago. Basic loss per share was TWD 0.68 compared to TWD 0.67 a year ago.